TScan Therapeutics Financial Overview
TScan Therapeutics's market cap is currently $50.83M. The company's EPS TTM is $-0.28; its P/E ratio is -0.80; TScan Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
